Therefore, for patients without available tissue biopsies, future studies could investigate the expression consistency of miRNAs targeting ACSL4, such as miR-211-5p [40], in both HCC tissue and plasma. The gene discussed is ACSL4; the disease is hepatocellular carcinoma.